Antirevmatiske medisiner - NKSR

Hopp til innhold

Bakgrunn for råd angående legemiddelbehandling

Abatacept (Orencia®)

Adalimumab (Amgevita®, Yuflyma®, Humira®, Hyrimoz®, Imraldi®)

Anakinra (Kineret®)

Anifrolumab (Saphnelo ®)

Apremilast (Otezla®)

Avakopan (Tavneos ®)

Azatioprin (Imurel®)

Baricitinib (Olumiant)

Belimumab (Benlysta®)

Bimekizumab (Bimzelx®)

Bosentan (Tracleer®)

Botulinumtoksin A

Canakinumab (Ilaris®)

Certolizumab (Cimzia®)

Ciklosporin (Sandimmun®)

Etanercept (Enbrel®, Benepali®, Erelzi®)

Filgotinib (Jyseleca®)

Golimumab (Simponi®)

Guselkumab (Tremfya®)

Hydroksyklorokin (Plaquenil®, Pimaxiro ®)

Iksekizumab (Taltz®)

Infliksimab (Remicade®, Flixabi®, Zessly®, Inflectra®, Remsima®)

IVIG/SCIG (intravenøs og subkutan IgG-behandling; Kiovig®, Panzyga®, Octagam®, Xembify®, Hizentra®)

Kolkisin (Kolkisin®, Colchicin®, Colrefuz®)

Kortikosteroider (prednisolon, kortison)

Leflunomid (Arava®)

Mepolizumab (Nucala®)

Metotreksat (Methotrexate®, Metex®, Nordimet®)

Metylprednisolon IV

Mykofenolat (CellCept®, Myfortix®)

Okrelizumab (Ocrevus ®)

Prostasyklinanaloger (Ilomedin®)

Risankizumab (Skyrizi®)

Rituksimab (MabThera®, Rixathon®)

Sekukinumab (Cosentyx®)

Sildenafil (Sildenafil®, Viagra®)

Sulfasalazin (Salazopyrin EN®)

Syklofosfamid (Sendoxan®)

Takrolimus (Prograf®)

Tocilizumab (RoActemra®)

Tofacitinib (Xeljanz®)

Upadacitinib (Rinvoq®)

Ustekinumab (Stelara®)

Voklosporin (Lupkynis®)

Acetylsalisylsyre

Denosumab (Prolia®)

Lavmolekylært heparin: Enoksaparin (Klexane®) og dalteparin (Fragmin®)

NSAID og selektive COX-2 hemmere

Teriparatid (Forsteo®)

Sist oppdatert 28.10.2025